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Mouse models are a crucial and often used tool to provide insight into the underlying mechanisms of
human atherosclerosis. However, mice profoundly differ from humans in lipoprotein synthesis and
metabolism, key factors in atherosclerotic plaque formation. Mouse models often require genetic and
dietary modiﬁcations to mimic human pathophysiology, shifting from a high-density lipoprotein to an
low-density lipoprotein dominant lipoprotein proﬁle. We examined the suitability of mice with a hu-
manized liver as a model for lipoprotein studies and studies on plaque formation, given the central role of
hepatocytes in lipoprotein synthesis and metabolism. Our results show a progressive humanization of
the mouse liver and a humanized lipoprotein proﬁle. However, no atherosclerotic plaque formation was
observed in the studied time frame, despite presence of functional macrophages and application of a
high cholesterol western-type diet. The humanized-liver mouse model therefore might require further
modiﬁcations to induce atherosclerosis, yet seems a valuable model for in vivo studies on lipoprotein
metabolism.
© 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cardiovascular disease (CVD) accounts for 31% of deaths
worldwide [1e4], and most cardiovascular events are a result of
atherosclerosis. Atherosclerosis is a lipid driven disease in which
lipids accumulate in the vessel wall. Once in the vessel wall,
oxidized lipids are engulfed by macrophages which in turn differ-
entiate into foam cells that trigger further plaque progression and
can eventually result in cardiovascular events. Serum lipoproteinsL, high density lipoproteins;
, NOD/Shi-scid/IL-2Rgnull; TK,
rokinase type plasminogen;
t.vanwolleghem@erasmusmc.
Inc. This is an open access article u
use model of humanized live
and Biophysical Research Coare circulating particles carrying different amounts of cholesterol,
hydrophobic lipid molecules and triglycerides [5] between organs
and are inevitably involved in lipid metabolism and related dis-
eases. Disturbances in lipoprotein metabolism therefore play a
crucial role in atherosclerotic plaque formation [6]. Animal models
of atherosclerosis that recapitulate human lipoprotein metabolism
are therefore essential tools to assess novel drugs or to study the
pathophysiology. However, mice and humans differ in fundamental
aspects of lipoprotein synthesis and metabolism.
The main differences in human and rodent lipoprotein physi-
ology are a circulating lipoprotein proﬁle dominant in high-density
lipoprotein (HDL) in mice opposed to a low-density lipoprotein
(LDL) dominant proﬁle in humans, a lack of cholesteryl ester
transfer protein (CETP) expression and lipoprotein (a), and a
different bile acid composition [7e9]. As a consequence, mice do
not develop atherosclerosis and require genetic, dietary and/or
mechanical modiﬁcations to be optimally applied as diseasender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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models available, each with their pros and cons, for example low-
density lipoprotein receptor knockout (ldlr/-), apolipoprotein E
knockout (ApoE/-) and C57Bl/6 mice carrying a mutation in pro-
tein convertase subtilisin/kexin type 9 (Pcsk9) gene [7]. Although
these models have their merits and are often used, they lack a
human-like lipid proﬁle. Experimental results can therefore not
always be readily translated to the human setting and testing of
lipid lowering drugs is difﬁcult. Humanization of the liver can be a
promising alternative to genetically modiﬁed models to mimic
human lipoprotein synthesis and metabolism.
Therefore, as an alternative to genetic models, we here examine
the humanization of the lipoprotein proﬁle and metabolization
pathways by transplanting human hepatocytes in mice with a ge-
netic (urokinase type plasminogen overexpression) or inducible
(thymidine kinase expression) liver damage [10e14] on an immu-
nodeﬁcient background. These mice have been shown to have a
human-like liver metabolization of xenobiotics and have been
applied for liver infectious disease studies, such as viral hepatitis
and malaria [15e18]. In the present study, our aim was to investi-
gate if human liver chimeric mice have a serum lipoprotein proﬁle
that can be applied as a model for atherosclerosis studies. After
demonstrating humanization of the lipoprotein proﬁle, we further
examined whether atherosclerotic plaques developed upon high
fat feeding. Despite 10-weeks of high fat diet, humanization of the
lipoprotein proﬁle, and presence of functional macrophages no
atherosclerotic plaques could be observed in the aortic vasculature
or carotid bifurcations.
2. Methods
2.1. Ethical permissions
All animal studies were approved by the animal ethics com-
mittee of the Erasmus University Medical Center (EMC 3019(141-
12-11)) and Maastricht University Medical Center (2018e011) and
conducted according to Dutch national guidelines.
2.2. Mouse origins and genotyping
The herpes simplex virus thymidine kinase (TK)/NOD/Shi-scid/
IL-2Rɣnullv(NOG) and urokinase-type plasminogen activator (uPA)/
NOGmice embryos were provided by dr. Suemizu, Central Institute
for Experimental Animals, Kawasaki, Japan [19]. Mice were bred at
the Central Animal Facility of the Erasmus Medical Center and
offspring zygosity was determined using a copy number duplex
qPCR performed on phenol-chloroform-isoamyl alcohol (Sigma-
Aldrich, St. Louis, MO, USA)-extracted genomic mouse DNA from
toe snips. The TaqMan Genotyping master mix (Life technologies,
Carlsbad, CA, USA) with the TaqMan uPA genotyping assay
(Mm00422051_cn; Life Technologies) or custom designed primer-
probe mix F: CGATTCGCCGCGTTTACG, R: CGCCGCCCTGCAGATA
and probe: [6FAM]CCGCACCGTATTGGCAA[BHQ1] targeting TK
gene and Tert gene references mix (Life technologies) were used
according to the manufacturer’s protocol.
Ldlr/- mice were obtained from the breeding colony of the
Maastricht University Medical Center research facilities. Serum
samples of HFD Ldlr/- mice were a kind gift from Dr. Menno
Hoekstra, Leiden Academic Centre for Drug Research, Leiden
University.
2.3. Human hepatocyte transplantation
TKþ and uPA-homozygous mice were anesthetized and trans-
planted with 0.5  106 to 2  106 viable cryopreserved humanPlease cite this article as: G. Sari et al., A mouse model of humanized live
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USA) via intrasplenic injection as previously described [16]. At
day 7 and 5 before transplantation, TK þ mice received an
intraperitoneal ganciclovir injection to initiate liver damage [19].
Engraftment level and transplantation success were determined
using a human albumin ELISA as previously described (Bethyl
laboratories, Montgomery, TX, USA) [16].
2.4. Animal housing and diet
Mice were fed al libitumwith pelleted rodent normal chow (Rat
and Mouse Breeder and Grower, CRM(P), Special Diet Services,
Essex, UK). For the high fat diet (HFD), animals were fed with food
containing 0,3% cholesterol (Altromin Spezialfutter GmbH& Co. KG,
Lage, Germany) up to 10 weeks. Ldlr-/- mice were fed with gamma
irradiated rodent chow from Ssniff (V1534-703, Soest, Germany).
For the hydragel analysis, positive control serum sample was ob-
tained from ldlr/- mice after the Western-type diet (diet W) con-
taining 0.25% cholesterol and 15% fat from Special Diet Services
(Witham, Essex).
2.5. Determining plaque presence ex vivo
Mice were euthanized via CO2 inhalation, after which their
blood was collected via cardiac puncture. Afterwards, the vascula-
ture was ﬂushed with 1x phosphate buffered saline (PBS) via the
left ventricle, followed by excision of the aorta and carotid arteries.
The arteries were cleaned from connective tissue and stained for
lipids (Oil red O (ORO)) to evaluate plaque presence. The arteries
were subsequently embedded in tissue-tec and stored at80 C for
histological analysis. 5 mm cryosections of the vasculature were
immunohistochemically stained with anti-CD68 (1:100 Biorad,
MCA1957) to assess if macrophages, which are the most prevalent
inﬂammatory cell in plaque, were present in the vasculature.
2.6. Hydragel analysis of lipoproteins
Hydragel analysis of lipoprotein proﬁles of serum samples was
performed using Hydragel 7 Lipoprotein(e) (Sebia Inc., Georgia,
USA) using a HYDRASYS System (Sebia Inc., Gergia, USA). Brieﬂy,
samples were loaded into wells of ready-to-use agarose gels (0,8 g/
dL) and electrophoresis was performed using buffered strips.
Samples were run at 160V for 20e25 min. Dried gels were stained
with a Sudan Black solution provided by the manufacturer, washed
with 75% ethanol and the migration pattern and lane density of the
samples were calculated. Area under the curve (AUC) calculation
was performed using GraphPad Prism 5 for Windows (v.5.01, 2007)
software.
2.7. Fast protein liquid chromatography (FPLC)
Fractionation of the lipoproteins was analyzed using FPLC. FPLC
gel ﬁltration was performed using a Tricorn Superdex 200
10e300 GL and a Tricorn Superose 6 10e300 GL size exclusion
column in series (GE Healthcare) on FPLC system (Pharmacia,1983).
2.8. RNA isolation, cDNA synthesis and qPCR analysis
RNA isolation was performed using whole liver tissues stored in
RNAlater RNA stabilization reagent (Qiagen, Hilden, Germany) with
RNeasy mini Kit (Qiagen, Hilden, Germany). Complementary DNA
(cDNA) was generated by using PrimeScript™ reverse transcriptase
master mix (Takara Bio Inc., Kusatsu, Japan) according to manu-
facturer’s protocol. Human speciﬁc CTEP gene expression was
measured using custom designed primers (F:r shows a human-like lipid proﬁle, but does not form atherosclerotic
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with PowerUp SYBR Green Master Mix (Thermo Fisher Scientiﬁc,
Waltham, MA, USA). Human speciﬁc GAPDH was applied as a
housekeeping control gene.2.9. FITC-labelled Escherichia coli (E.coli) phagocytosis assay
Splenocytes were isolated from uPAþ/þ mice and ldlr/- mice
spleen using 100 mm cell strainer. Cells were counted using Trypan
blue staining and 2  108 cells were incubated with 200 mg/ml FITC
labelled E.coli (Glycotope, Germany) either at 4 or 37 for 45 min.
Following incubation, free or unbound E.coli was removed by
washing and cells were stained with Aqua-Amcyan, CD45-APC
(30F11, eBioscience48-0451-82), CD11c-APC-Cy7 (N418, Biolegend
117324), CD11b-PE-Cy7 (M1/70, eBioscience 25e011282) and F4/
80-APC (BM8, eBioscience 17-4801-82) and measured using a
multi-color ﬂow cytometer (Canto II) for detection of splenic
macrophages and elimination of dendritic cells as described pre-
viously [20] (for gating strategy see Supp. Fig.1). After gating on
splenic macrophages, the ratio of the FITC-positive and enegative
cell population was analyzed to document their phagocytic activity
using FlowJo (v.10, Tree Star Inc.).2.10. Statistical analysis
GraphPad Prism 5.01 forWindows (GraphPad Software, Inc., San
Diego California USA) was used for statistical analysis and illus-
trations. Spearman r was applied for the statistical analysis of the
association, and p < 0.05 was accepted as statistically signiﬁcant.Fig. 1. Human liver chimeric mice adopt a human-like lipoprotein proﬁle during progress
periments. B. Sudan black lane intensity on agarose gel electrophoresis blots of chimeric an
line) levels in FPLC fractions of a humanized mouse serum sample. VLDL and LDL peaks can
the mouse serum lipoprotein pool. As HDL predominates the lipoprotein pool in mouse seru
peak in serum agarose gel electrophoresis studies (AUC(LDL þVLDL)\AUC(HDL)) (*p < 0.01 a
(p < 0.05; Spearman r ¼ 0.5760). (For interpretation of the references to color in this ﬁgur
Please cite this article as: G. Sari et al., A mouse model of humanized live
plaque after western type diet, Biochemical and Biophysical Research Co3. Results
3.1. Human liver chimeric NOG mice adopt a human-like serum
lipoprotein proﬁle
To demonstrate humanization of the serum lipoprotein proﬁle
of human liver chimeric mice, we analyzed serum samples before
and after human hepatocyte transplantation (Fig. 1A) with agarose
gel electrophoresis and subsequent visualization with Sudan black.
Lipoproteins are separated based on their size dependentmigration
differences in this assay (HDL-fast, LDL-slow and VLDL
eintermediate migration). In addition, the requirement of small
sample volumes, allows us to analyze the lipoprotein proﬁle of the
same animal at multiple time points. As shown in Fig. 1B, human
liver chimeric NOG mice demonstrate merged VLDL and LDL bands
with increased intensity compared to non-transplanted mice. To
examine the constituents of the merged peaks, we analyzed larger
volumes (>150 mL) of serum samples obtained at sacriﬁce using
FPLC. Fig. 1C shows a representative example of cholesterol and
triglyceride concentrations per FPLC fraction. Elutes with high
cholesterol concentrations correspond to HDL, the elutes with high
triglyceride concentrations correspond to VLDL, while LDL has in-
termediate levels of both cholesterol and triglycerides. FPLC data
could therefore conﬁrm that both LDL and VLDL are abundantly
present in humanized mouse sera, suggesting a humanization of
the lipoprotein proﬁle. We then compared human and humanized
mouse serum lipoprotein proﬁles by analyzing the ratio of
VLDL þ LDL to HDL, as the former are predominantly present in
human sera, while the latter is predominantly present in wild type
mouse serum. We therefore calculated the area under the curve
(AUC) of the respective lipoprotein peaks after gel electrophoresis.
The AUC ratio of (VLDL þ LDL)/HDL is signiﬁcantly higher inive liver repopulation by human hepatocytes. A. Schematic representation of the ex-
d non-chimeric mouse serum samples. C. Triglyceride (grey line) and cholesterol (blue
be discerned based on their different elution proﬁles during FPLC. D. Humanization of
m, humanization was expressed by combining LDL and VLDL peaks, divided by the HDL
nd & p < 0.0001). E. This AUC ratio correlates with mouse serum human albumin levels
e legend, the reader is referred to the Web version of this article.)
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ratio observed for human serum (Fig. 1D) (* and #p < 0.01). In
addition, the AUC ratio of (VLDL þ LDL)/HDL positively correlates
with serum human albumin levels in human hepatocyte trans-
planted mice (Fig. 1E), which is an indicator of human hepatocyte
engraftment success (p< 0.05). Overall these data demonstrate that
successful repopulation of the liver with human hepatocytes leads
to a progressive humanization of the mouse serum lipoprotein
proﬁle.Fig. 3. Splenic macrophages of uPA ± NOG mice phagocyte E.coli to a lesser extent
compared to those of ldlr/- mice. Splenic macrophages were incubated for 45 min at
4 C or 37 C with or without FITC-labelled E.coli and analyzed by FACS. Each dot shows
an individual mouse. N ¼ 4 for both mouse strains.3.2. Despite functional macrophages and a high fat diet, human
liver chimeric mice are not prone to atherosclerotic plaque
formation
A human like lipoprotein proﬁle is the prerequisite for athero-
sclerotic plaque formation in animal models of atherosclerosis. We
therefore explored predilection zones in the vasculature (aortic
arch and carotid artery bifurcations) of humanized mice for
atherosclerotic plaques. However, no plaques were detected after
14 weeks of normal chow diet (data not shown). Atherosclerotic
mouse models often require at least 8e10 weeks of HFD (HFD, 0.3%
cholesterol), resulting in high LDL levels before atherosclerotic
plaques can be detected. We therefore fed humanized mice a HFD
(0.3% cholesterol) for up to 10 weeks (Fig. 2A). This HFD resulted in
a signiﬁcant increase in total serum cholesterol levels (Fig. 2B),
characterized by an increase of all lipoprotein levels on gel elec-
trophoresis studies (normal chow serum vs week 8 HFD serum and
normal chow serum vs week 10 HFD serum, p < 0.05; Fig. 2C).
Besides higher LDL and VLDL levels, macrophages are essential
for plaque formation. Hence, we next examined the phagocytic
capacity of macrophages isolated from uPANOG mice. We
compared them tomacrophages of ldlr/- mice as a positive control,
plaque formation can be observed in these mice due to high serumFig. 2. Human liver chimeric mouse serum cholesterol levels increase following high fat
experiments. B. Serum cholesterol levels of human liver chimeric mice during HFD. C. Su
samples (n ¼ 6) of human liver chimeric mice (n ¼ 4, red/orange/green/blue lines) and ldlr/-
dotted surface area) or HFD (all other mice). D. Perfused and ORO stained artery of a huma
arterial lumen after a longitudinal incision. The arrows indicate common locations of plaque
aorta, the white arrow indicates the inner curve of the aorta. No ORO stained tissue is visib
human liver chimeric mouse after 10 weeks of HFD. (For interpretation of the references t
Please cite this article as: G. Sari et al., A mouse model of humanized live
plaque after western type diet, Biochemical and Biophysical Research CoLDL levels. Isolated splenocytes from uPANOG mice were able to
phagocytose FITC-labelled E.coli, although the ratio of FITC posi-
tivity was 20e30% less than the splenic macrophages of ldlr/- mice
(Fig. 3). Despite the increases in total cholesterol and LDL and VLDL
levels, no lipid accumulations (via ORO staining) or
CD68 þ expressing cells (a marker of macrophages) were observed
in the mouse vasculature within the tested time window (Fig. 2D
and 2E).
4. Discussion
We and others have shown that the human liver chimericdiet (HFD) without signiﬁcant plaque formation. A. Schematic representation of the
dan black lane intensity per pixel position after agarose gel electrophoresis of serum
mice (n ¼ 2, black line and grey surface area) fed with either normal chow (red line and
n liver chimeric mouse after 10 weeks of HFD. The inset shows a zoomed image of the
formation: the black arrow indicates the location between two branching arteries of the
le in the arteries. E. CD68 staining, as a marker of macrophages, of the aortic arch of a
o color in this ﬁgure legend, the reader is referred to the Web version of this article.)
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research areas, including viral hepatitis and drug metabolism
studies [15e18]. In the present study we assessed the human liver
chimeric mouse as a candidate model for lipoprotein related dis-
ease studies. As is known, the mouse serum lipoprotein pool con-
sists of HDL predominantly [21]. As shown in Fig. 1, repopulation of
the mouse liver after transplantation of human hepatocytes leads
to higher serum VLDL and LDL levels. Furthermore, this humani-
zation of serum lipoproteins correlates with serum human albumin
levels, a marker of successful and progressive liver humanization.
Inﬂammation and a disturbed lipid metabolism are crucial in
atherosclerotic plaque initiation and progression. Most animal
models mimic the human pathophysiology by interventions like a
genetic modiﬁcation such as ApoE or ldlr knock outs, PCSK9 knock-
in and/or dietary modiﬁcations next to the genetic modiﬁcation [7].
Different physiological mechanisms underlie this murine resistance
to atherosclerosis: a different composition of mouse bile acid and
salts, a lack of CETP expression and formation of lipoprotein (a), and
also higher serumHDL to LDL ratios [7e9]. Because the human liver
chimeric mouse model has humanized lipoprotein ratios, we hy-
pothesized that the model might have the potential to be applied in
atherosclerosis research without any genetic modiﬁcations altering
the lipid metabolism. It is important to stress that in addition to
humanized lipoprotein ratios and the presence of high amounts of
oxidized LDL the presence, migration and also phagocytocytic ca-
pacity of macrophages are other key steps in atherosclerotic plaque
formation [22],. As both uPANOG and TKNOG mice have an
immunodeﬁcient, IL-2Rɣnull background, we ﬁrst demonstrated a
preserved ealbeit reducede E. coli phagocytic activity of splenic
macrophages compared to ldlr/- mice. Secondly, we found a HFD
diet induced increase in serum total cholesterol levels, which is
comparable to ApoE/ but lower than ldlr/- mouse fed with HFD
[23,24] accompanied by elevations in LDL and VLDL fractions, but
also an increase in serumHDL. These lipid changes did not however
result in an accumulation of plaques in the aortic vasculature after a
period of 10 weeks. The latter would normally sufﬁce to induce
plaque formation in ldlr/- mice [25].
Several reasons might explain why our model does not
demonstrate atherosclerotic plaque formation, despite having a
humanized lipoprotein proﬁle, functional macrophages and a
substantial period of high fat diet. First, while LDL and VLDL in-
crease, HDL shows a similar increase after HFD. The HDL increase
might be reﬂecting the response of remaining mouse hepatocytes
in chimeric livers to an increase in dietary cholesterol and provide
anti-inﬂammatory signals that prevent plaque formation [26e29].
Second, the observed increase in LDL and VLDL is still lower than
that of the ldlr/- control mouse strain, which is prone to plaques.
Third, Kupffer cell derived CETP governs the composition of circu-
lating human lipoproteins, but is not expressed inmice so that mice
carry the serum cholesterol in HDL [21]. Liver humanized mice
harbor only human hepatocytes, and no CETP mRNA was detected
in chimeric mouse livers (data not shown). Finally, other inﬂam-
matory cells which are not present in NOG mice might be required
for inﬂammatory crosstalk and plaque initiation.
To conclude, our data show that along with the humanization of
the liver, a progressive humanization of the serum lipoprotein
proﬁle is induced in human liver chimeric mice. This model
therefore offers unique opportunities for translational studies on
lipoprotein metabolism. Furthermore, having the advantage of
harboring differentiated human hepatocytes, without any genetic
changes, this model promises to be a tool for pharmacological
studies of novel lipid lowering drugs that speciﬁcally act at the
hepatocyte level. In addition, the model might be applied to study
the roles of other inﬂammatory cells in the formation of athero-
sclerotic plaques via adoptive cell transfer experiments.Please cite this article as: G. Sari et al., A mouse model of humanized live
plaque after western type diet, Biochemical and Biophysical Research CoImportantly, high fat diet and the presence of functional macro-
phages were found to be insufﬁcient to initiate atherosclerotic
plaque formation within the tested time window. These data sug-
gest that extra factors or modiﬁcations are required for athero-
sclerotic plaque formation such as other immune cells, or longer
durations of HFD.
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